Christoph Hock, MD, is Full Professor at the Medical Faculty, University of Zurich, as well as Co-Director and Head Physician at the Division of Psychiatry Research and Psychogeriatric Medicine, Psychiatric University Hospital Zurich, Switzerland. In his research activities, Dr. Hock has contributed to both clinical therapeutic and diagnostic studies in Alzheimer’s disease (AD). He served as principal investigator for a number of international, multi-center studies with experimental medications in AD including recent strategies based on immunization. His publications in the dementia field were ranked among the most highly cited papers in neuroscience. Dr. Hock received consistent peer-reviewed funding by the Swiss National Science Foundation and European Union. He is a member of the Research Council of the Swiss National Science Foundation as well as numerous professional societies and serves as Editor-in-Chief of the scientific journal Neurodegenerative Diseases (Karger, Basel). Dr. Hock supported actively the development of translational medicine, by connecting basic research to patient care (“bench to bedside”); in this field he served also as scientific advisor to biotech and pharmaceutical companies, venture capital firms and as co-founder of Neurimmune AG and imCare AG, Zurich.
